CVE-2026-94016 SourceCodester Drug Recommendation System add_symptom cross site scripting
Attackers can inject malicious scripts via the txtname parameter in the admin symptom addition feature, potentially compromising user sessions.
- Exploited in the wild
- Not known
- Login needed
- An administrator
- Attackable
- Over the internet
- Victim action needed
- A user has to click or open something
- Fix
- None listed
What is CVE-2026-94016?
CVE-2026-94016 is a medium-severity cross-site scripting vulnerability in SourceCodester Drug Recommendation System, published on 20 Sep 2026. An attacker needs administrator access to exploit it, and only if a user opens a file or follows a link.
Official description
A security flaw has been discovered in SourceCodester Drug Recommendation System 1.0. This impacts an unknown function of the file /drug_recommender/Admin/add_symptom. Performing a manipulation of the argument txtname results in cross site scripting. Remote exploitation of the attack is possible. The exploit has been released to the public and may be used for attacks.
Which versions are affected by CVE-2026-94016?
How do I fix CVE-2026-94016?
No fix has been published for CVE-2026-94016 yet. Limit exposure of the affected software until one is available.
Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.
Is CVE-2026-94016 being exploited?
It is not confirmed as exploited in the wild, but public exploit code for CVE-2026-94016 exists.
Sources
Also known as GHSA-j97g-6cp9-956m.